Filter News
Area of Research
- (-) Materials (12)
- (-) Nuclear Science and Technology (4)
- Advanced Manufacturing (4)
- Biology and Environment (6)
- Building Technologies (1)
- Clean Energy (20)
- Climate and Environmental Systems (1)
- Computational Engineering (3)
- Computer Science (11)
- Isotopes (5)
- Materials for Computing (5)
- Mathematics (1)
- National Security (2)
- Neutron Science (2)
- Quantum information Science (4)
- Supercomputing (25)
News Topics
- (-) Climate Change (1)
- (-) Composites (3)
- (-) Computer Science (4)
- (-) Isotopes (4)
- (-) Molten Salt (3)
- (-) Polymers (3)
- 3-D Printing/Advanced Manufacturing (8)
- Advanced Reactors (4)
- Bioenergy (4)
- Biology (1)
- Biomedical (2)
- Chemical Sciences (1)
- Clean Water (1)
- Critical Materials (1)
- Cybersecurity (2)
- Energy Storage (4)
- Environment (2)
- Frontier (1)
- Fusion (4)
- ITER (1)
- Materials (4)
- Materials Science (20)
- Microscopy (9)
- Nanotechnology (13)
- Neutron Science (9)
- Nuclear Energy (12)
- Physics (5)
- Quantum Computing (1)
- Quantum Science (4)
- Space Exploration (3)
- Sustainable Energy (4)
- Transportation (4)
Media Contacts
Physicists turned to the “doubly magic” tin isotope Sn-132, colliding it with a target at Oak Ridge National Laboratory to assess its properties as it lost a neutron to become Sn-131.
Scientists at the Department of Energy’s Oak Ridge National Laboratory used neutrons, isotopes and simulations to “see” the atomic structure of a saturated solution and found evidence supporting one of two competing hypotheses about how ions come
Experts focused on the future of nuclear technology will gather at Oak Ridge National Laboratory for the fourth annual Molten Salt Reactor Workshop on October 3–4.
An Oak Ridge National Laboratory–led team has developed super-stretchy polymers with amazing self-healing abilities that could lead to longer-lasting consumer products.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.